View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
February 5, 2020updated 13 Feb 2020 10:51am

UK scientist claims to fast track development of coronavirus vaccine

A scientist in the UK, Robin Shattock, said his research team was able to reduce a part of the development timeline from the standard two to three years to 14 days, reported Sky news.


Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates


Follow the latest updates of the outbreak on our timeline.

A scientist in the UK, Robin Shattock, said his research team was able to reduce a part of the development timeline from the standard two to three years to 14 days, reported Sky news.

Professor Shattock, head of mucosal infection and immunity at Imperial College London, is said to be currently at the animal testing phase, scheduled to begin next week.

Shattock was quoted by the news agency as saying: “Conventional approaches usually take at least two to three years before you even get to the clinic. And we’ve gone from that sequence to generating a candidate in the laboratory in 14 days.

“And we will have it in animal models by the beginning of next week. We’ve short-tracked that part. The next phase will be to move that from early animal testing into the first human studies. And we think with adequate funding we could do that in a period of a few months.”

This development is part of a global effort to develop a vaccine to address the ongoing coronavirus outbreak. It is estimated that a vaccine would take at least a year to be commercially available.

Earlier this week, the UK government committed £20m to develop vaccines for the coronavirus, as well as other infectious diseases.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology